We are thrilled to announce a significant step forward in advancing genomics in Malaysia!
On January 29, 2026, GeneMind signed a tripartite Memorandum of Understanding (MoU) with AGTC Genomics and Interscience Sdn Bhd in Kuala Lumpur. This collaboration marks a committed effort to enhance genomics research and clinical applications across the region.
Our CTO, Sun Lei, expressed deep appreciation for the trust and partnership from the leadership and scientific teams of AGTC Genomics and Interscience Sdn Bhd. He highlighted that this MoU is not merely a document—it reflects our shared commitment to turning genomic data into real-world clinical impact.
Together, we are pushing the boundaries of precision medicine.
